共 50 条
[31]
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
[J].
Leukemia,
2012, 26
:1675-1680
[33]
Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma
[J].
Annals of Hematology,
2008, 87
:253-254
[40]
Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
[J].
JOURNAL OF RESEARCH IN MEDICAL SCIENCES,
2012, 17 (01)
:8-14